TrialAnnals of oncology : official journal of the European Society for Medical Oncology2019

An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial).

C R Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.